Drug prices
Drug pricing in the US is complex and controversial. Here’s what you need to know about the factors that contribute to high drug prices, potential solutions, and more.
Latest
STAT Plus: Despite new Wegovy coverage, Medicare patients may face high drug costs and other hurdles
EU adviser says Illumina merger was not problematic
BioNTech is having its Pfizer moment
STAT Plus: Pharma companies and their allies seek to exempt orphan drugs from state pricing limits
Novo is building a really big computer
STAT Plus: New gene therapy, to be priced at $4.25 million, has already transformed children’s lives
STAT Plus: Contineum Therapeutics files for IPO
All Coverage
advertisement
